XML 50 R37.htm IDEA: XBRL DOCUMENT v3.25.2
Segment Reporting (Tables)
6 Months Ended
Jun. 30, 2025
Segment Reporting [Abstract]  
Schedule of Significant Segment Expenses, Segment Net Revenues, and the Segment Performance Measure, Net Loss The following table presents the details of the significant segment expenses, segment net revenues, and the segment performance measure, net loss, in the periods indicated:

 

 

Three Months Ended June 30,

 

 

Six Months Ended June 30,

 

 

2025

 

 

2024

 

 

2025

 

 

2024

 

Total revenue

$

135,000

 

 

$

215,565

 

 

$

270,000

 

 

$

418,629

 

 

 

 

 

 

 

 

 

 

 

 

Less significant expenses:

 

 

 

 

 

 

 

 

 

 

 

Professional fees

 

946,850

 

 

 

782,698

 

 

 

1,832,441

 

 

 

1,350,390

 

Operations and research (excluding compensation)

 

528,955

 

 

 

871,714

 

 

 

932,654

 

 

 

1,597,997

 

Compensation:

 

 

 

 

 

 

 

 

 

 

 

Salaries and Wages

 

2,987,147

 

 

 

831,074

 

 

 

3,728,687

 

 

 

1,709,903

 

Share-based compensation

 

45,742

 

 

 

101,785

 

 

 

91,484

 

 

 

1,564,532

 

Total Compensation

 

3,032,889

 

 

 

932,859

 

 

 

3,820,171

 

 

 

3,274,435

 

Total Significant Expenses

 

4,508,694

 

 

 

2,587,271

 

 

 

6,585,266

 

 

 

6,222,822

 

Other segment items (gain)/loss (1)

 

12,765,803

 

 

 

1,357,021

 

 

 

11,239,885

 

 

 

(2,996,434

)

Total Significant Expenses and Other Segment Items

$

17,274,497

 

 

$

3,944,292

 

 

$

17,825,151

 

 

$

3,226,388

 

 

 

 

 

 

 

 

 

 

 

 

Net Income/(Loss)

$

(17,139,497

)

 

$

(3,728,727

)

 

$

(17,555,151

)

 

$

(2,807,759

)

 

(1)
Includes other expenses within Marketing, General and Administrative and Operations and Research which are not significant individually or in the aggregate and not included within Significant Expenses above; as well as, Interest income, Interest Expense, Loss on equity method investment, Change in derivative liabilities fair value, and Other, as reported in our condensed consolidated statements of operations.